Next Article in Journal
Ginsenosides Enhanced Apoptosis of Serum-Free Starved A549 Lung Cancer Cells
Previous Article in Journal
Next-Generation Wastewater-Based Epidemiology: Green Automation for Detecting 69 Multiclass Pharmaceutical and Personal Care Products in Wastewater Using 96-Well Plate Solid-Phase Extraction by LC-MS/MS
Previous Article in Special Issue
Investigation of Mechanochromic and Solvatochromic Luminescence of Cyclometalated Heteroleptic Platinum(II) Complexes with Benzoylthiourea Derivatives
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Utility of the Redox Cycle of Nitrofurantoin for the Development of a New Chemiluminescence Method for Its Analysis in Milk Samples

by
Mahmoud El-Maghrabey
1,2,
Ali Abdel-Hakim
1,3,
Shiho Tagaya
1,
Naotaka Kuroda
1 and
Naoya Kishikawa
1,*
1
Graduate School of Biomedical Sciences, Nagasaki University, 1-14 Bunkyo-machi, Nagasaki 852-8521, Japan
2
Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt
3
Department of Analytical Chemistry, Faculty of Pharmacy, University of Sadat City, Sadat City 32897, Egypt
*
Author to whom correspondence should be addressed.
Molecules 2025, 30(18), 3698; https://doi.org/10.3390/molecules30183698
Submission received: 31 July 2025 / Revised: 7 September 2025 / Accepted: 8 September 2025 / Published: 11 September 2025
(This article belongs to the Special Issue Chemiluminescence and Photoluminescence of Advanced Compounds)

Abstract

Nitrofurantoin is utilized in various industries, including dairy, livestock, poultry, and aquaculture, as a growth promoter and antibacterial agent. Because prolonged use can cause mutagenesis and other side effects, many countries have prohibited its use in food-producing animals. In this work, we introduce a simple, rapid, and highly sensitive chemiluminescence (CL) approach for the quantitation of nitrofurantoin using its redox cycle activity. Nitrofurantoin is reduced to nitrofurantoin radicals by the reducing agent dithiothreitol, and reactive oxygen species (ROS) formed during the reoxidation process (superoxide anion radical) are detected by luminol CL. The CL conditions were optimized, including types of solvents, CL and reducing reagents, and their concentrations. The method was validated as per International Council for Harmonization (ICHQ2(R2)) guidelines, regarding linearity, detection and quantitation limits, accuracy, and precision. A good linearity with r = 0.9992 was obtained between the CL intensity and the nitrofurantoin concentration in the range of 4.0–400.0 ng/mL with a high sensitivity down to 1.15 ng/mL. The method was utilized to determine nitrofurantoin in milk samples, and a good recovery range was obtained (97.5–103.1%; RSD ≤ 4.4%); the results were comparable to the reported method, demonstrating the method’s reliability. Finally, the method demonstrated good practicality using a recently developed assessment tool.

1. Introduction

Nitrofurantoin ((E)-1-[(5-nitro-2-furyl) methylideneamino]imidazolidine-2,4-dione) is an antibiotic approved by the Food and Drug Administration (FDA) in 1953 and has been used to treat urinary tract infections [1,2]. It has also been used as a growth promoter and to treat bacterial infections in many industries, including dairy, livestock, poultry, and aquaculture [3,4,5]. The long-term use of nitrofurantoin can cause many side effects, including pulmonary fibrosis and hepatotoxicity [6]. Long-term studies using bacteria isolated from wastewater have shown that nitrofurantoin is mutagenic [7]; therefore, its use in food-producing animals is prohibited in many countries, including Australia, the United States, the Philippines, Thailand, Brazil, and Japan [8,9]. However, owing to its effectiveness and low cost, it is still used illegally in many countries and regions, especially in developing countries. Therefore, a highly sensitive and rapid quantitative method for nitrofurantoin is needed.
The methods published for the quantitative estimation of nitrofurantoin include high-performance liquid chromatography (HPLC) with ultraviolet (UV) detector (HPLC-UV) [10,11] ultra-high-performance liquid chromatography (UHPLC) with UV detector (UHPLC-UV) [12], UHPLC coupled with high-field quadrupole-Orbitrap high-resolution mass spectrometric detection (UHPLC-QE HF HRMS) [13], UV-visible spectrophotometry [14,15], fluorescence spectroscopy [16,17,18], optical methods [19,20], surface-enhanced Raman spectroscopy (SERS) [21,22,23], and voltammetry [24,25,26,27,28]. However, UV-visible spectrophotometry and optical methods generally exhibit poor sensitivities. Although SERS is a common quantitative method for nitrofurantoin owing to its high sensitivity and selectivity, it utilizes specific nanostructures prepared by complicated procedures. Chromatographic and voltammetric methods are highly sensitive and selective; however, they require complex and expensive equipment and time-consuming procedures. Fluorometric methods for nitrofurantoin analysis [16,17,18] have some drawbacks, such as the need for the preparation of carbon dots, and their detection mechanisms are based on the inner-filter effect, which affects their selectivity. In addition, they have poor sensitivity.
In this study, we focused on chemiluminescence (CL) as a method to rapidly and sensitively quantify nitrofurantoin, using relatively simple equipment. CL is a phenomenon in which an excited state molecule, generated by receiving energy from a chemical reaction, releases energy as light when it returns to a stable ground state [29]. The CL method does not need an excitation light source; therefore, it is possible to detect with high sensitivity without noise or scattered light from the light source, and it has the advantage of being able to measure with relatively simple equipment. Taokaenchan et al. [30] introduced a CL-based method for the estimation of nitrofurantoin. The technique used tris(2,2′-bipyridyl)ruthenium(II) as a CL reagent, but the method also used quantum dots capped with cysteine, which require a long synthesis time (more than 5 h), and the technique exhibited relatively poor sensitivity (0.6 μM). In another study, nitrofurantoin was determined by CL using a bis(2,4,6-trichlorophenyl) oxalate–H2O2 system [31]. However, this method requires the synthesis of a molecularly imprinted polymer (MIP), which complicates the procedure. Luminol is another CL reagent that emits intense light through reactive oxygen species (ROS) during the oxidation process and therefore has various applications [32]. The Luminol-H2O2 system was applied for post-column CL detection of nitrofurantoin [33]. However, chromatographic analysis followed by a post-column reaction makes this method more sophisticated.
Our laboratory has focused on analyzing quinones and their use as derivatizing agents in innovative and versatile ways [34,35,36,37]. We have developed a novel approach for quantitative CL analysis of quinones, in which they generate ROS [37,38] through a new CL reaction mechanism. Quinones are known to be reduced to radical species by the action of NADPH oxidoreductase, in vivo, by the donation of electrons from NADPH, which converts dissolved oxygen into ROS. Our CL reaction approach is based on the principle that dithiothreitol (DTT) is used as a reducing agent instead of NADPH to reduce quinones to radical species, and the ROS generated as a result is detected by CL with luminol. On the other hand, it has been reported that nitrofurantoin is reduced to radical species by the action of NADPH oxidoreductase and generates ROS, thereby oxidizing and decomposing bacteria and exerting an antibacterial effect [39] as illustrated in Figure 1. Therefore, we hypothesized that nitrofurantoin could also be quantitatively determined by CL using DTT and luminol as reagents, similar to quinones.
Figure 2 shows an outline of the quantitative CL method that utilizes the redox cycle of nitrofurantoin, which is reduced by DTT to an unstable nitrofurantoin anion radical, which reacts with dissolved oxygen in the solution and is reoxidized, generating ROS. The ROS generated at this time can be detected by the CL using luminol, and the CL corresponding to the concentration of nitrofurantoin can be measured.
In this study, we optimized various reaction conditions, such as the type and concentration of the reagents, to establish a CL quantitative method for nitrofurantoin. Then, the method was validated and applied for the quantitative estimation of nitrofurantoin in milk samples, and the results obtained were compared with a reported method [17] to further prove the validity of the proposed method. Also, we identified the type of ROS involved in the CL using a selective ROS scavenger to confirm the mechanism of CL by nitrofurantoin.

2. Results and Discussion

2.1. CL Profile of Luminol/DTT/Nitrofurantoin System

The CL profiles of the luminol/DTT/nitrofurantoin system obtained by measuring nitrofurantoin solutions with different concentrations covering a range of 4.0–400.0 ng/mL under the established measurement operating conditions (described in Section 3.5) are shown in Figure 3. Stable CL was observed for more than 10 min immediately after the addition of DTT. Furthermore, the CL signal increased with increasing nitrofurantoin concentration, indicating its suitability for the quantitative determination of nitrofurantoin using the CL generated from its reaction with DTT and luminol.

2.2. Optimization of CL Reaction Conditions

Various CL reaction conditions were optimized, such as the type and concentration of the CL reagent, type and concentration of the reducing agent, acetonitrile (ACN) content in nitrofurantoin solution, and NaOH concentration in luminol solution.

2.2.1. Selection of CL Reagent

Five CL reagents were examined for detecting ROS generated by nitrofurantoin: luminol, luminol derivative L-012, lucigenin, 2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo [1,2-a]pyrazin-3-one (MCLA), and 2-methyl-6-phenyl-3,7-dihydroimidazo [1,2-a]pyrazin-3-one (CLA), which are analogs of Cypridina luciferin. CL measurements were performed three times, and the optimal conditions were evaluated by comparing the average values of the integrated CL and the signal/blank (S/B) ratio. The S/B ratio was calculated by dividing the integrated CL of the sample by the integrated CL of the blank. As shown in Figure 4, strong CL was obtained when lucigenin, L-012, and luminol were used as CL reagents, while the S/B ratio was maximized when luminol was used. Therefore, luminol was chosen as the optimal CL reagent in this work.

2.2.2. Effect of Luminol Concentration

The luminol concentration was investigated in the range of 100–600 µM. As shown in Figure 5, both the S/B ratio and integrated CL increased with increasing luminol concentration over a concentration range of 100–400 µM and reached a maximum and constant value at concentrations of 400 µM or more. Based on these results and taking robustness into consideration, 500 µM was chosen as the optimal luminol concentration.

2.2.3. Effect of the Type of Reducing Agent

Four reducing agents, DTT, sodium borohydride (NaBH4), L-cysteine, and ascorbic acid, were used to reduce nitrofurantoin to radical species and compared. As shown in Figure 6, the maximum integrated CL was obtained when NaBH4 was used as the reducing agent, whereas the S/B ratio was the highest when DTT was used. Based on these results, DTT was selected as the optimal reducing agent for this study.

2.2.4. Effect of DTT Concentration

DTT concentration was investigated in the range of 400–800 µM. The maximum S/B ratio and integrated CL were achieved at 600 µM DTT (Figure 7). Therefore, 600 µM was chosen as the optimal DTT concentration for further experiments.

2.2.5. Effect of ACN Content in Nitrofurantoin Solvent

The ACN content in the solvent used to prepare the nitrofurantoin solution was optimized in the range of 5–30%. The maximum S/B ratio and integrated CL were achieved with 15% ACN (Figure 8). Therefore, 15% ACN was chosen as the optimal ACN content for the nitrofurantoin solvent.

2.2.6. Effect of NaOH Concentration

Since luminol produces strong CL under alkaline conditions [40], the NaOH concentration in the solvent used to prepare the luminol solution was optimized in the range of 10–70 mM. As shown in Figure 9, the integrated CL and S/B ratio increased with increasing NaOH concentration. The integrated CL reached a nearly maximum and constant value at 40 mM or higher, and the S/B ratio slightly decreased at concentrations higher than 50 mM. Based on these results, 50 mM of NaOH was selected as the optimal concentration.

2.3. Identification of ROS Produced by CL of Nitrofurantoin

To elucidate the nitrofurantoin CL mechanism, the impact of selective ROS scavengers on CL produced by the three-component reaction of nitrofurantoin, DTT, and luminol was investigated in an attempt to identify the ROS that contribute to CL.
The quenching effect of selective ROS scavengers on CL generated by the reaction of nitrofurantoin, DTT, and luminol was examined. Superoxide dismutase (SOD) (1, 10 U/mL) was used as a selective ROS scavenger to quench O2·−, mannitol (10, 100 µM) and methanol (1, 10%) for OH, and sodium azide (NaN3) (10, 100 µM) for 1O2 [37,41]. As shown in Table 1, a notable decrease in the CL was observed with the addition of SOD. However, the quenching effect was not very high when ROS scavengers such as mannitol, methanol, and sodium azide were added. Therefore, it was suggested that the main ROS involved in the CL of nitrofurantoin was O2·−. This result is consistent with a previous report that nitrofurantoin exerts its bactericidal effect by generating O2·− through an oxidation-reduction reaction in vivo [39].

2.4. Method Validation

The proposed approach was validated according to the International Council for Harmonization (ICHQ2(R2)) guidelines for validation of analytical procedures [42]. The calibration curve of the nitrofurantoin standard solution was prepared under optimal conditions. A good linear relationship was obtained between the nitrofurantoin concentration and integrated CL intensity, with a correlation coefficient of 0.9992 in the concentration range of 4.0–400.0 ng/mL. The limit of detection (LOD) and limit of quantitation (LOQ) were calculated using the standard deviation (S.D.) of the blank and slope of the calibration curve. The LOD and LOQ of this method were 1.15 ng/mL and 3.45 ng/mL, respectively. The accuracy and precision of the proposed CL method were assessed using five nitrofurantoin levels within the method’s linear range. The % recovery of triplicate analysis of each concentration ranged from 98.0 to 102.5%, indicating the excellent accuracy of the developed method. The relative standard deviation (RSD) was not more than 5.5% for intra-day precision, and 8.6% for inter-day precision, indicating the good precision of the proposed CL method. The results of the accuracy and precision of the method are presented in Table 2.
The sensitivity of this method for nitrofurantoin was compared with that of conventional quantitative methods, as shown in Table 3. The sensitivity of this CL method was 8.7–973 times higher than that of chromatographic methods with UV detectors [10,11,12], 141 times higher than that of the UV-visible spectrophotometric method [15], 8.7–289 times higher than that of the fluorescence spectroscopic methods [16,17,18], 18.6–173 times higher than that of the optical methods [19,20], 4.3–43.4 times higher than that of the SERS methods [21,22,23], and 1.7–9.9 times higher than that of the voltammetric methods [24,25,26,27,28]. Compared with the mass spectrometric-based method [13], this CL method was less sensitive than the mass spectrometric-based method. Although the sensitivity of the CL method is inferior, considering the measurement time and procedures required for one analysis, the CL method is considered superior in terms of simplicity and speed. This is because the developed CL method utilizes simple and cost-effective equipment (luminometer) and avoids the consumption of highly toxic organic solvents and the high energy associated with chromatographic analysis and MS detection. In addition, the mass spectrometric-based method uses a metal–organic framework, which is prepared in more than 12 h, making the method sophisticated and time-consuming. Therefore, the developed CL method is deemed to be more suitable for rapid analysis, particularly in resource-limited settings.

2.5. Application of the Developed Method for the Determination of Nitrofurantoin in Milk Samples

The developed CL method was used to analyze milk samples. First, non-spiked samples were assayed, and nitrofurantoin was absent from these samples. This is mostly because veterinary use of nitrofurantoin is banned in Japan, as mentioned earlier. Analysis of the non-spiked samples using the reported method also yielded the same results. Therefore, spiked samples were analyzed to evaluate the applicability of the method. As shown in Table 4, the proposed method achieved excellent recovery of nitrofurantoin from milk, ranging from 97.5% to 103.1%, indicating its applicability for determining nitrofurantoin in milk samples. Furthermore, the precision of the repeated measurements (n = 5) was calculated, and the RSD was not more than 4.4%, which demonstrates the excellent reliability of the developed method. To further confirm the validity of the developed method, its outcomes were statistically compared to the outcomes of the reported method [17], using Student’s t-test and F-test for variance ratio. As shown in Table 4, the calculated t and F values were lower than the tabulated values, indicating the absence of significant differences between the developed and published methods in terms of accuracy and precision.

2.6. Evaluation of the Method’s Practicability

Recently, a new tool named the Blue Applicability Grade Index (BAGI) was established to evaluate the practicability (blueness) of analytical methodologies. This method considers 10 attributes: the type of analysis, number of analytes concurrently assayed, instrumentation, number of samples simultaneously prepared, procedure for preparing the samples, number of samples analyzed in one hour, type of chemicals used, need for preconcentration, and sample quantity [43]. A score was assigned to each attribute. The lowest score is 2.5, and the highest score is 10. The lowest overall score is 25, and the highest overall score is 100. The overall score is the summation of all scores for all attributes and is determined by the tool’s software. The software also generates an asteroid graph, where each attribute is given a color (dark blue, the optimum, moderate blue, light blue, or white, the worst). For the analytical method to be considered practical, it must achieve an overall score of at least 60. Table 5 presents the blueness assessment of the developed method using the BAGI approach. The proposed method achieved a final score of 67.5, demonstrating good practicality.

3. Materials and Methods

3.1. Materials and Reagents

Luminol, DTT, sodium hydroxide (NaOH), L-cysteine, and chloroform were provided by Nacalai Tesque, Inc. (Kyoto, Japan). Nitrofurantoin, lucigenin, NaBH4, MCLA, and CLA were provided by Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). L-012, ascorbic acid, trichloroacetic acid, SOD, and sodium azide were purchased from Fujifilm Wako Pure Chemical Co., Ltd. (Osaka, Japan). Methanol and ACN were purchased from Kanto Chemical Co., Ltd. (Tokyo, Japan). Mannitol was provided by Sigma-Aldrich (St. Louis, MO, USA).
Luminal solution was prepared using an aqueous NaOH solution. Nitrofurantoin solution was prepared using an ACN aqueous solution and diluted to the desired concentration.

3.2. Equipment and Software

All the CL measurements were conducted using a Lumat LB-9507 luminometer (Berthold Technologies, Bad Wildbad, Germany), with a total integration time of 600 s, using 12 × 75 mm round-bottom test tubes (Fisher Scientific, Pittsburgh, PA, USA).
An ultrasonic cleaner, SND US-102 (Nagano, Japan), a Himac CR refrigerated centrifuge (Hitachi, Tokyo, Japan), and an automatic mixer S-100 (Taiyo Kagaku Kogyo Co., Ltd., Tokyo, Japan) were used for sonication, centrifugation, and mixing, respectively.
Yamato Autosill WG220 water purification device (Yamato Scientific Co., Ltd., Tokyo, Japan) was used to obtain the purified water.
Terumo syringes (1 mL, Terumo Medical Corp., Tokyo, Japan) fitted with hydrophilic PTFE 0.45 µm FILSTAR syringe filters (Starlab Scientific Co., Ltd., Beijing, China) were used for the preparation of milk samples.
Blueness assessment of the developed CL method by the BAGI tool was performed using the freely available web version of the tool at (https://bagi-index.anvil.app/, accessed on 25 August 2025), by selecting the most appropriate choice from the drop-down list of each evaluated parameter. Then, the generated graph was saved as a .png image. The chemical structures in Figure 1 and Figure 2 were generated using ACD/ChemSketch (freeware) version 2025.1.0.

3.3. Procedure for Optimization of CL Conditions

The CL conditions were optimized using a one-factor-at-a-time approach, in which one factor was studied at a time, while the other factors remained constant. The studied factors were the type and concentration of the CL reagent, the type and concentration of the reducing agent, ACN content in the nitrofurantoin solution, and NaOH concentration in the luminol solution. The following conditions were used unless stated otherwise (100 µL of 80.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL of 500 µM luminol in 50 mM NaOH(aq), 100 µL of 600 µM DTT in H2O, and a total integration time of 600 s). In all cases, a blank experiment was conducted concurrently. Blank samples were prepared using the same procedure but with the replacement of the nitrofurantoin solution with 100 µL of 15% ACN(aq). The integrated CL and S/B ratios were used to determine the optimum conditions.

3.4. Procedure for Identification of ROS Responsible for the CL of Nitrofurantoin

One hundred microliters of luminol (500 µM in 50 mM NaOH solution), nitrofurantoin (40.0 ng/mL in 15% ACN), and an aqueous solution of ROS scavengers were added to a test tube and stirred for 5 s. The test tube was placed in a luminometer, followed by the addition of 100 µL of 600 µM aqueous solution of DTT, and the CL generated was measured for 600 s. The CL measurement was repeated three times.

3.5. Procedure for Method Validation

The developed method was validated following ICHQ2(R2) guidelines [42]. To construct the calibration curve, 100 µL of 500 µM luminol in 50 mM NaOH solution and 100 µL of 15% ACN solution with different concentrations of nitrofurantoin (to obtain a final concentration range of 4.0–400.0 ng/mL) were added to a series of test tubes and stirred for 5 s. The tubes were placed in a luminometer, and 100 µL of 600 µM DTT solution was added, and the resulting CL was measured for 600 s. CL measurements were repeated three times. The integrated CL values were plotted against the nitrofurantoin concentration (ng/mL) to construct a calibration curve. LOD and LOQ were estimated as LOD = 3.3 S.D. of blank/slope of the calibration curve, and LOQ = 10 S.D. of blank/slope of the calibration curve. Accuracy and precision were evaluated at five nitrofurantoin levels (8.0, 40.0, 80.0, 160.0, and 400.0 ng/mL). Each concentration was analyzed three times, and the average % recovery was determined using the regression equation to evaluate the accuracy of the method. The precision was evaluated by determining the %RSD for each concentration. The experiments were conducted on the same day (intra-day precision) and on three successive days (inter-day precision).

3.6. Determination of Nitrofurantoin in Milk Samples

The method reported by Liu et al. [44] was used for the extraction of nitrofurantoin from milk, with some modifications. Non-spiked milk samples were prepared by adding 800 µL of 10% trichloroacetic acid solution to 200 µL of the milk samples to remove proteins. Then, 1 mL of chloroform was added, and the mixture was shaken for 1 min and ultrasonicated for 20 min. The mixture was then centrifuged for 10 min, and the upper aqueous layer was collected. This upper layer was neutralized with 0.5 M NaOH aqueous solution, filtered through a membrane filter, diluted 10 times using 15% ACN solution, and used for CL measurement.
Spiked milk samples were prepared by adding different concentrations of nitrofurantoin (to obtain final concentrations of 40.0, 80.0, and 400.0 ng/mL) to 200 µL of milk samples, followed by the addition of 800 µL of a 10% trichloroacetic acid solution to remove proteins. They were then completed using the same steps as those used for the non-spiked samples.

4. Conclusions

In this study, the redox cycle of nitrofurantoin was utilized to develop a CL method for its analysis for the first time, where ROS are produced upon a reduction of nitrofurantoin by DTT, and the generated ROS reacted with luminol to produce CL. This method is simple, reliable, and cost-effective. It showed good linearity, sensitivity, accuracy, and precision, in addition to good applicability to milk samples, which is a very complicated matrix. The method’s excellent sensitivity was superior to that of most reported analytical methods for the estimation of nitrofurantoin. In addition, the method showed a good blueness profile, further indicating its applicability to real sample analysis. Future investigations should focus on expanding the scope of the application of the developed method beyond milk samples to include other food matrices and biological fluids. In addition, using a selective extraction approach such as MIP or integration of chromatographic separation prior to CL detection would resolve possible interference and allow for further broadening the scope of the method. Although this is deemed unnecessary in the analysis of milk samples by the developed method, it might be helpful if other compounds capable of redox cycling or generating ROS are present in other food matrices or biological fluids being investigated.

Author Contributions

Conceptualization, M.E.-M. and N.K. (Naoya Kishikawa); methodology, M.E.-M., S.T. and N.K. (Naoya Kishikawa); software, M.E.-M., A.A.-H. and S.T.; validation, M.E.-M. and S.T.; formal analysis, A.A.-H. and S.T.; investigation, M.E.-M., A.A.-H., S.T. and N.K. (Naoya Kishikawa); resources, M.E.-M., N.K. (Naotaka Kuroda) and N.K. (Naoya Kishikawa); data curation, M.E.-M., A.A.-H. and S.T.; writing—original draft preparation, A.A.-H.; writing—review and editing, A.A.-H., M.E.-M., N.K. (Naotaka Kuroda) and N.K. (Naoya Kishikawa); Visualization, M.E.-M., N.K. (Naotaka Kuroda) and N.K. (Naoya Kishikawa); supervision, M.E.-M., N.K. (Naotaka Kuroda) and N.K. (Naoya Kishikawa); project administration, N.K. (Naotaka Kuroda) and N.K. (Naoya Kishikawa); funding acquisition, N.K. (Naotaka Kuroda) and N.K. (Naoya Kishikawa). All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
CLChemiluminescence
ROSReactive Oxygen Species
ICHInternational Council for Harmonization
FDAFood and Drug Administration
HPLCHigh-Performance Liquid Chromatography
UHPLCUltra-High-Performance Liquid Chromatography
UVUltraviolet
QE HF HRMSHigh-Field Quadrupole-Orbitrap High Resolution Mass Spectrometry
SERSSurface-Enhanced Raman Spectroscopy
MIPMolecularly Imprinted Polymer
DTTDithiothreitol
ACNAcetonitrile
MCLA2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo [1,2-a]pyrazin-3-one
CLA2-methyl-6-phenyl-3,7-dihydroimidazo [1,2-a]pyrazin-3-one
S/BSignal to Blank Ration
SODSuperoxide dismutase
RCIRelative CL Intensity
LODLimit of Detection
LOQLimit of Quantitation
S.D.Standard Deviation
RSDRelative Standard Deviation
BAGIBlue Applicability Grade Index

References

  1. Cvetkovski, A.; Ferretti, V. Crystal Structure and Packing Analysis of Nitrofurantoin N,N-Dimethylformamide Solvate. Crystallogr. Rep. 2016, 61, 611–615. [Google Scholar] [CrossRef]
  2. Huttner, A.; Verhaegh, E.M.; Harbarth, S.; Muller, A.E.; Theuretzbacher, U.; Mouton, J.W. Nitrofurantoin Revisited: A Systematic Review and Meta-Analysis of Controlled Trials. J. Antimicrob. Chemother. 2015, 70, 2456–2464. [Google Scholar] [CrossRef] [PubMed]
  3. Guichard, P.; Laurentie, M.; Hurtaud-Pessel, D.; Verdon, E. Confirmation of Five Nitrofuran Metabolites Including Nifursol Metabolite in Meat and Aquaculture Products by Liquid Chromatography-Tandem Mass Spectrometry: Validation According to European Union Decision 2002/657/EC. Food Chem. 2021, 342, 128389. [Google Scholar] [CrossRef] [PubMed]
  4. Antunes, P.; Mourão, J.; Campos, J.; Peixe, L. Salmonellosis: The Role of Poultry Meat. Clin. Microbiol. Infect. 2016, 22, 110–121. [Google Scholar] [CrossRef] [PubMed]
  5. Tripathi, A.; Suriyamoorthy, P.; Rawson, A. Nitrofuran Residues in Animal Sourced Food: Sample Extraction and Identification Methods—A Review. Food Chem. Adv. 2023, 3, 100396. [Google Scholar] [CrossRef]
  6. Bessone, F.; Ferrari, A.; Hernandez, N.; Mendizabal, M.; Ridruejo, E.; Zerega, A.; Tanno, F.; Reggiardo, M.V.; Vorobioff, J.; Tanno, H.; et al. Nitrofurantoin-Induced Liver Injury: Long-Term Follow-up in Two Prospective DILI Registries. Arch. Toxicol. 2023, 97, 593–602. [Google Scholar] [CrossRef]
  7. Pacholak, A.; Żur-Pińska, J.; Piński, A.; Nguyen, Q.A.; Ligaj, M.; Luczak, M.; Nghiem, L.D.; Kaczorek, E. Potential Negative Effect of Long-Term Exposure to Nitrofurans on Bacteria Isolated from Wastewater. Sci. Total Environ. 2023, 872, 162199. [Google Scholar] [CrossRef]
  8. Ahmed, F.; Kokulnathan, T.; Umar, A.; Akbar, S.; Kumar, S.; Shaalan, N.M.; Arshi, N.; Alam, M.G.; Aljaafari, A.; Alshoaibi, A. Zinc Oxide/Phosphorus-Doped Carbon Nitride Composite as Potential Scaffold for Electrochemical Detection of Nitrofurantoin. Biosensors 2022, 12, 856. [Google Scholar] [CrossRef]
  9. Kijima, A.; Ishii, Y.; Takasu, S.; Matsushita, K.; Kuroda, K.; Hibi, D.; Suzuki, Y.; Nohmi, T.; Umemura, T. Chemical Structure-Related Mechanisms Underlying in Vivo Genotoxicity Induced by Nitrofurantoin and Its Constituent Moieties in Gpt Delta Rats. Toxicology 2015, 331, 125–135. [Google Scholar] [CrossRef]
  10. Damayanti, S.; Gunawan, U.; Ibrahim, S. Development of Molecular Imprinted Polymer Solid Phase Extraction (MISPE) for Separation Nitrofurantoin Residue in Chicken Eggs. Asian J. Pharm. Clin. Res. 2017, 10, 108. [Google Scholar] [CrossRef]
  11. Ibrahim, E.; Sallam, S.; Hadad, G. Simultaneous Determination of Nitrofurantoin and Phenazopyridine in Human Urine Samples by HPLC-UV. Rec. Pharm. Biomed. Sci. 2023, 7, 10–20. [Google Scholar] [CrossRef]
  12. Wijma, R.A.; Hoogtanders, K.E.J.; Croes, S.; Mouton, J.W.; Brüggemann, R.J.M. Development and Validation of a Fast and Sensitive UHPLC-DAD Assay for the Quantification of Nitrofurantoin in Plasma and Urine. J. Pharm. Biomed. Anal. 2019, 174, 161–167. [Google Scholar] [CrossRef] [PubMed]
  13. Suo, D.; Song, Z.; Xiao, Z.; Wang, S.; Shang, W.; Du, Q.; Fan, X.; Wang, P. Enrichment and Determination of Nine Nitrofurans in Aquaculture Water and Aquatic Feed by Using Metal–Organic Framework NDO-Zn. Microchem. J. 2023, 190, 108639. [Google Scholar] [CrossRef]
  14. Karajgi, S.R.; Sunayana, M.; Potdar, S.S.; Kotnal, R.B. Novel First Order Derivative UV- Spectrophotometric Peak Detect Method for the Determination of Nitrofurantoin. Int. J. ChemTech Res. 2018, 11, 239–246. [Google Scholar] [CrossRef]
  15. Hadi, H.; Mouayed, M. Spectrophotometric Determination of Nitrofurantoin Drug in Its Pharmaceutical Formulations Using MBTH as a Coupling Reagent. Iraqi J. Pharm. Sci. 2017, 25, 7–14. [Google Scholar] [CrossRef]
  16. Al-Hashimi, B.R.; Omer, K.M.; Rahman, H.S.; Othman, H.H. Inner Filter Effect as a Sensitive Sensing Platform for Detection of Nitrofurantoin Using Luminescent Drug-Based Carbon Nanodots. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2021, 244, 118835. [Google Scholar] [CrossRef]
  17. El Sharkasy, M.E.; Tolba, M.M.; Belal, F.; Walash, M.I.; Aboshabana, R. Turn-off Fluorescence of S,N-Doped Carbon Dots for Determination of Two Nitro-Containing Drugs in Dosage Forms and Human Plasma. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2023, 289, 122246. [Google Scholar] [CrossRef]
  18. Liu, J.; Yang, B.; Wang, Y.; Zhang, F.; Liu, X.; Niu, S.; Yuan, Y.; Bi, S. Sensitive Detection of Furazolidone and Nitrofurantoin by Fluorescent Nanoprobe Coated with 3-Mercaptopropionic Acid on CdS Quantum Dots. Microchem. J. 2024, 197, 109773. [Google Scholar] [CrossRef]
  19. Yue, X.; Zhou, Z.; Li, M.; Jie, M.; Xu, B.; Bai, Y. Inner-Filter Effect Induced Fluorescent Sensor Based on Fusiform Al-MOF Nanosheets for Sensitive and Visual Detection of Nitrofuran in Milk. Food Chem. 2022, 367, 130763. [Google Scholar] [CrossRef]
  20. Cheng, Z.; Liu, X.; Zhao, B.; Liu, X.; Yang, X.; Zhang, X.; Feng, X. A Smartphone-Integrated Test Paper Sensing Platform for Visual and Intelligent Detection of Nitrofurantoin in Honey Samples. Food Chem. 2024, 445, 138783. [Google Scholar] [CrossRef]
  21. Zhang, Y.; Yu, Z.; Yue, Z.; Gao, J.; Wu, S.; Zhang, Z.; Li, G. Rapid Determination of Trace Nitrofurantoin in Cosmetics by Surface Enhanced Raman Spectroscopy Using Nanoarrayed Hydroxyl Polystyrene-based Substrate. J. Raman Spectrosc. 2019, 50, 1094–1102. [Google Scholar] [CrossRef]
  22. Zhang, H.; Lai, H.; Wu, X.; Li, G.; Hu, Y. CoFe2O4@HNTs/AuNPs Substrate for Rapid Magnetic Solid-Phase Extraction and Efficient SERS Detection of Complex Samples All-in-One. Anal. Chem. 2020, 92, 4607–4613. [Google Scholar] [CrossRef]
  23. Wang, Y.; Chen, H.; Jiang, L. A Highly Reproducible SERS Sensor Based on an Au Nanoparticles/Graphene Oxide Hybrid Nanocomposite for Label-Free Quantitative Detection of Antibiotics. Analyst 2021, 146, 5740–5746. [Google Scholar] [CrossRef] [PubMed]
  24. Kokulnathan, T.; Wang, T.-J. Synthesis and Characterization of 3D Flower-like Nickel Oxide Entrapped on Boron Doped Carbon Nitride Nanocomposite: An Efficient Catalyst for the Electrochemical Detection of Nitrofurantoin. Compos. Part B Eng. 2019, 174, 106914. [Google Scholar] [CrossRef]
  25. Mariyappan, V.; Keerthi, M.; Chen, S.-M.; Jeyapragasam, T. Nanostructured Perovskite Type Gadolinium Orthoferrite Decorated RGO Nanocomposite for the Detection of Nitrofurantoin in Human Urine and River Water Samples. J. Colloid Interface Sci. 2021, 600, 537–549. [Google Scholar] [CrossRef] [PubMed]
  26. Li, M.; Zhe, T.; Li, R.; Bai, F.; Jia, P.; Xu, Z.; Wang, X.; Bu, T.; Wu, H.; Wang, L. ZIF-Derived Co Nanoparticles Embedded into N-Doped Carbon Nanotube Composites for Highly Efficient Electrochemical Detection of Nitrofurantoin in Food. Food Chem. 2023, 418, 135948. [Google Scholar] [CrossRef]
  27. Babulal, S.M.; Koventhan, C.; Chen, S.M.; Hung, W. Construction of Sphere like Samarium Vanadate Nanoparticles Anchored Graphene Nanosheets for Enhanced Electrochemical Detection of Nitrofurantoin in Biological Fluids. Compos. Part B Eng. 2022, 237, 109847. [Google Scholar] [CrossRef]
  28. Amin, A.; Prasad, G.V.; Vinothkumar, V.; Jang, S.J.; Oh, D.E.; Kim, T.H. Reduced Graphene Oxide/β-Cyclodextrin Nanocomposite for the Electrochemical Detection of Nitrofurantoin. Chemosensors 2025, 13, 247. [Google Scholar] [CrossRef]
  29. Tzani, M.A.; Gioftsidou, D.K.; Kallitsakis, M.G.; Pliatsios, N.V.; Kalogiouri, N.P.; Angaridis, P.A.; Lykakis, I.N.; Terzidis, M.A. Direct and Indirect Chemiluminescence: Reactions, Mechanisms and Challenges. Molecules 2021, 26, 7664. [Google Scholar] [CrossRef]
  30. Taokaenchan, N.; Tangkuaram, T.; Pookmanee, P.; Phaisansuthichol, S.; Kuimalee, S.; Satienperakul, S. Enhanced Electrogenerated Chemiluminescence of Tris(2,2′-Bipyridyl)Ruthenium(II) System by l-Cysteine-Capped CdTe Quantum Dots and Its Application for the Determination of Nitrofuran Antibiotics. Biosens. Bioelectron. 2015, 66, 231–237. [Google Scholar] [CrossRef]
  31. Zhang, X.-Y.; Liu, J.-X.; Jiang, Z.-Q.; Wang, J.-P. Molecularly Imprinted Polymer Based Chemiluminescence Method for Detection of Nitrofurans. Aust. J. Chem. 2019, 72, 375. [Google Scholar] [CrossRef]
  32. Deepa, S.; Venkatesan, R.; Jayalakshmi, S.; Priya, M.; Kim, S.-C. Recent Advances in Catalyst-Enhanced Luminol Chemiluminescence System and Its Environmental and Chemical Applications. J. Environ. Chem. Eng. 2023, 11, 109853. [Google Scholar] [CrossRef]
  33. Satienperakul, S.; Tatana, C.; Taokaenchan, N.; Sirikeaw, W.; Liawruangrath, S. Determination of Selected Nitrofurans Using High Performance Liquid Chromatography with Post-Column Chemiluminescence Detection. Maejo Int. J. Sci. Technol. 2017, 11, 249–263. [Google Scholar]
  34. El-Maghrabey, M.; Kishikawa, N.; Kuroda, N. Novel Isotope-Coded Derivatization Method for Aldehydes Using 14 N/ 15 N-Ammonium Acetate and 9,10-Phenanthrenequinone. Anal. Chem. 2018, 90, 13867–13875. [Google Scholar] [CrossRef]
  35. El-Maghrabey, M.; Kishikawa, N.; Kuroda, N. 9,10-Phenanthrenequinone as a Mass-Tagging Reagent for Ultra-Sensitive Liquid Chromatography-Tandem Mass Spectrometry Assay of Aliphatic Aldehydes in Human Serum. J. Chromatogr. A 2016, 1462, 80–89. [Google Scholar] [CrossRef]
  36. El-Maghrabey, M.; Kishikawa, N.; Harada, S.; Ohyama, K.; Kuroda, N. Quinone-Based Antibody Labeling Reagent for Enzyme-Free Chemiluminescent Immunoassays. Application to Avidin and Biotinylated Anti-Rabbit IgG Labeling. Biosens. Bioelectron. 2020, 160, 112215. [Google Scholar] [CrossRef]
  37. El-Maghrabey, M.; Kishikawa, N.; Kamimura, S.; Ohyama, K.; Kuroda, N. Design of a Dual Functionalized Chemiluminescence Ultrasensitive Probe for Quinones Based on Their Redox Cycle. Application to the Determination of Doxorubicin in Lyophilized Powder and Human Serum. Sens. Actuators B Chem. 2021, 329, 129226. [Google Scholar] [CrossRef]
  38. Fukuda, M.; El-Maghrabey, M.H.; Kishikawa, N.; Ikemoto, K.; Kuroda, N. Ultrasensitive Determination of Pyrroloquinoline Quinone in Human Plasma by HPLC with Chemiluminescence Detection Using the Redox Cycle of Quinone. J. Pharm. Biomed. Anal. 2017, 145, 814–820. [Google Scholar] [CrossRef]
  39. Kim, S.Y.; Park, C.; Jang, H.-J.; Kim, B.; Bae, H.-W.; Chung, I.-Y.; Kim, E.S.; Cho, Y.-H. Antibacterial Strategies Inspired by the Oxidative Stress and Response Networks. J. Microbiol. 2019, 57, 203–212. [Google Scholar] [CrossRef]
  40. Giussani, A.; Farahani, P.; Martínez-Muñoz, D.; Lundberg, M.; Lindh, R.; Roca-Sanjuán, D. Molecular Basis of the Chemiluminescence Mechanism of Luminol. Chem—A Eur. J. 2019, 25, 5202–5213. [Google Scholar] [CrossRef]
  41. Carlsson, C.; Fégeant, B.; Svensson, E.; Wiklund, L.; Jonsson, M. On the Selectivity of Radical Scavengers Used to Probe Hydroxyl Radical Formation in Heterogeneous Systems. J. Phys. Chem. C 2022, 126, 12435–12440. [Google Scholar] [CrossRef]
  42. International Council for Harmonisation. Validation of Analytical Procedures Q2(R2); International Council for Harmonisation: Geneva, Switzerland, 2022. [Google Scholar]
  43. Manousi, N.; Wojnowski, W.; Płotka-Wasylka, J.; Samanidou, V. Blue Applicability Grade Index (BAGI) and Software: A New Tool for the Evaluation of Method Practicality. Green Chem. 2023, 25, 7598–7604. [Google Scholar] [CrossRef]
  44. Liu, M.; Zhe, T.; Zhu, L.; Li, F.; Ma, K.; Xuan, C.; Feng, Q.; Ouyang, S.; Wang, L. Interfacial Engineering of VS2/Ti3C2Tx MXene Heterojunctions for Portable Electrochemical Sensing of Nitrofurantoin Residues in Food and Water Samples. Food Chem. 2025, 486, 144624. [Google Scholar] [CrossRef]
Figure 1. Illustration of the nitrofurantoin redox cycle.
Figure 1. Illustration of the nitrofurantoin redox cycle.
Molecules 30 03698 g001
Figure 2. CL detection of nitrofurantoin based on its redox cycle.
Figure 2. CL detection of nitrofurantoin based on its redox cycle.
Molecules 30 03698 g002
Figure 3. CL time profile for the reaction of luminol/DTT/nitrofurantoin system. [Conditions: 100 µL of 4.0–400.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL of 500 µM luminol in 50 mM NaOH(aq), and 100 µL of 600 µM DTT in H2O].
Figure 3. CL time profile for the reaction of luminol/DTT/nitrofurantoin system. [Conditions: 100 µL of 4.0–400.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL of 500 µM luminol in 50 mM NaOH(aq), and 100 µL of 600 µM DTT in H2O].
Molecules 30 03698 g003
Figure 4. Effects of CL reagent on CL intensity and the S/B ratio of nitrofurantoin CL. [Conditions: 100 µL 80.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL 500 µM CL reagent in 6 mM NaOH(aq), and 100 µL 600 µM DTT in H2O]. The black arrow indicates the optimum condition.
Figure 4. Effects of CL reagent on CL intensity and the S/B ratio of nitrofurantoin CL. [Conditions: 100 µL 80.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL 500 µM CL reagent in 6 mM NaOH(aq), and 100 µL 600 µM DTT in H2O]. The black arrow indicates the optimum condition.
Molecules 30 03698 g004
Figure 5. Effects of luminol concentration on CL intensity and S/B ratio of nitrofurantoin CL. [Conditions: 100 µL of 80.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL of 100–600 µM luminol in 6 mM NaOH(aq), and 100 µL of 600 µM DTT in H2O]. The black arrow indicates the optimum condition.
Figure 5. Effects of luminol concentration on CL intensity and S/B ratio of nitrofurantoin CL. [Conditions: 100 µL of 80.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL of 100–600 µM luminol in 6 mM NaOH(aq), and 100 µL of 600 µM DTT in H2O]. The black arrow indicates the optimum condition.
Molecules 30 03698 g005
Figure 6. Effects of reducing agent on CL intensity and S/B ratio of nitrofurantoin CL. [Conditions: 100 µL of 80.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL of 500 µM luminol in 6 mM NaOH(aq), and 100 µL of 600 µM reductants in H2O]. The black arrow indicates the optimum condition.
Figure 6. Effects of reducing agent on CL intensity and S/B ratio of nitrofurantoin CL. [Conditions: 100 µL of 80.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL of 500 µM luminol in 6 mM NaOH(aq), and 100 µL of 600 µM reductants in H2O]. The black arrow indicates the optimum condition.
Molecules 30 03698 g006
Figure 7. Effects of DTT concentration on CL intensity and the S/B ratio of nitrofurantoin CL. [Conditions: 100 µL of 80.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL of 500 µM luminol in 6 mM NaOH(aq), and 100 µL of 400–800 µM DTT in H2O]. The black arrow indicates the optimum condition.
Figure 7. Effects of DTT concentration on CL intensity and the S/B ratio of nitrofurantoin CL. [Conditions: 100 µL of 80.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL of 500 µM luminol in 6 mM NaOH(aq), and 100 µL of 400–800 µM DTT in H2O]. The black arrow indicates the optimum condition.
Molecules 30 03698 g007
Figure 8. Effects of ACN content in nitrofurantoin solvent on CL intensity and S/B ratio of nitrofurantoin CL. [Conditions: 100 µL of 80.0 ng/mL nitrofurantoin in 5–30% ACN(aq), 100 µL of 500 µM luminol in 6 mM NaOH(aq), and 100 µL of 600 µM DTT in H2O]. The black arrow indicates the optimum condition.
Figure 8. Effects of ACN content in nitrofurantoin solvent on CL intensity and S/B ratio of nitrofurantoin CL. [Conditions: 100 µL of 80.0 ng/mL nitrofurantoin in 5–30% ACN(aq), 100 µL of 500 µM luminol in 6 mM NaOH(aq), and 100 µL of 600 µM DTT in H2O]. The black arrow indicates the optimum condition.
Molecules 30 03698 g008
Figure 9. Effects of NaOH concentration on CL intensity and S/B ratio of nitrofurantoin CL. [Conditions: 100 µL 80.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL 500 µM luminol in 10–70 mM NaOH(aq), and 100 µL 600 µM DTT in H2O]. The black arrow indicates the optimum condition.
Figure 9. Effects of NaOH concentration on CL intensity and S/B ratio of nitrofurantoin CL. [Conditions: 100 µL 80.0 ng/mL nitrofurantoin in 15% ACN(aq), 100 µL 500 µM luminol in 10–70 mM NaOH(aq), and 100 µL 600 µM DTT in H2O]. The black arrow indicates the optimum condition.
Molecules 30 03698 g009
Table 1. Effect of selective ROS scavengers on CL production by nitrofurantoin, DTT, and luminol.
Table 1. Effect of selective ROS scavengers on CL production by nitrofurantoin, DTT, and luminol.
ScavengerROSConcentrationRCI *
No scavenger100
SODO2·−1 U/mL0.61
10 U/mL0.25
MannitolOH10 μM56.4
100 μM47.9
MethanolOH1%71.1
10%52.8
NaN31O210 μM63.6
100 μM53.7
* RCI refers to relative CL intensity. The value was taken as 100 for nitrofurantoin with luminol and DTT without a scavenger.
Table 2. Results of the accuracy and precision study of nitrofurantoin using the proposed CL method.
Table 2. Results of the accuracy and precision study of nitrofurantoin using the proposed CL method.
Concentration Added (ng/mL)Recovery (%)Intra-Day Precision (RSD, %)Inter-Day Precision (RSD, %)
8.0102.53.38.6
40.098.01.42.4
80.099.55.56.2
160.099.85.56.0
400.0101.31.21.8
Table 3. Comparison of the sensitivity of the proposed method with previously reported methods.
Table 3. Comparison of the sensitivity of the proposed method with previously reported methods.
MethodRange (ng/mL)LOD (ng/mL)Ref.
HPLC-UV10,000–100,0001119[10]
HPLC-UV200–20,00010[11]
UHPLC-UV50–125027[12]
UHPLC-QE HF HRMS1–1000.3[13]
UV-visible spectrophotometry5000–25,000[14]
UV-visible spectrophotometry500–30,000163[15]
Fluorescence spectroscopy11,900–21,420333[16]
Fluorescence spectroscopy500–8000140[17]
Fluorescence spectroscopy570–28,58010[18]
Optical detection200–19,040200[19]
Optical detection21.4–38,08021.4[20]
SERS500–10,00050[21]
SERS50–100014[22]
SERS5–5005[23]
Voltammetry12–54,7402.4[24]
Voltammetry3.6–59,2623.6[25]
Voltammetry12–130,9004.4[26]
Voltammetry8.3–160,0072[27]
Voltammetry119–28,56011.4[28]
CL4.0–400.01.15This method
Table 4. Determination of nitrofurantoin in milk samples using the proposed CL method and the reported method.
Table 4. Determination of nitrofurantoin in milk samples using the proposed CL method and the reported method.
Proposed MethodReported Method [17]
Concentration Added (ng/mL)Recovery (%)Precision (RSD, %)Concentration Added (ng/mL)Recovery (%)
0Not detected0Not detected
40.0103.12.3500.096.4
80.099.53.51000.0102.3
400.097.54.41500.095.7
Mean recovery ± S.D.100.03 ± 2.8398.13 ± 3.62
t-test (2.776) *0.71
F-test (19.00) *1.63
* The values in parentheses are the tabulated t and F values at p = 0.05.
Table 5. Evaluation of the practicability of the proposed method using the BAGI tool.
Table 5. Evaluation of the practicability of the proposed method using the BAGI tool.
AttributeResultColorPictogram
  • Type of analysis
QuantitativeModerate blue
2.
Analyte number
Single elementWhileMolecules 30 03698 i001
3.
Analytical technique
Simple instrumentsModerate blue
4.
Simultaneous sample preparation
1White
5.
Sample preparation
Simple, low-cost sample preparation requiredModerate blue
6.
Samples per hour
5–10Moderate blue
7.
Reagents and materials
Common commercially available reagentsDark blue
8.
Preconcentration
Not neededDark blue
9.
Degree of automation
Manual treatment and analysisWhite
10.
Sample quantity
Less than 10 mL of the food sampleDark blue
Overall score67.5
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

El-Maghrabey, M.; Abdel-Hakim, A.; Tagaya, S.; Kuroda, N.; Kishikawa, N. Utility of the Redox Cycle of Nitrofurantoin for the Development of a New Chemiluminescence Method for Its Analysis in Milk Samples. Molecules 2025, 30, 3698. https://doi.org/10.3390/molecules30183698

AMA Style

El-Maghrabey M, Abdel-Hakim A, Tagaya S, Kuroda N, Kishikawa N. Utility of the Redox Cycle of Nitrofurantoin for the Development of a New Chemiluminescence Method for Its Analysis in Milk Samples. Molecules. 2025; 30(18):3698. https://doi.org/10.3390/molecules30183698

Chicago/Turabian Style

El-Maghrabey, Mahmoud, Ali Abdel-Hakim, Shiho Tagaya, Naotaka Kuroda, and Naoya Kishikawa. 2025. "Utility of the Redox Cycle of Nitrofurantoin for the Development of a New Chemiluminescence Method for Its Analysis in Milk Samples" Molecules 30, no. 18: 3698. https://doi.org/10.3390/molecules30183698

APA Style

El-Maghrabey, M., Abdel-Hakim, A., Tagaya, S., Kuroda, N., & Kishikawa, N. (2025). Utility of the Redox Cycle of Nitrofurantoin for the Development of a New Chemiluminescence Method for Its Analysis in Milk Samples. Molecules, 30(18), 3698. https://doi.org/10.3390/molecules30183698

Article Metrics

Back to TopTop